|
|
|
Company
Name |
Short
Summary |
| BioBalance |
The
philosophy behind Bio Balance is that accurate
descriptions of drug-receptor interactions will
lead to the development of better pharmaceuticals.
Bio Balance is devoted to a biophysical description
of the initial receptor response. |
| Bristol-Myers
Squibb |
Bristol-Myers
Squibb is a leading diversified worldwide health
and personal care company whose principal businesses
are medicines, beauty care, nutritionals, and
medical devices. |
| Callisto
Pharmaceuticals |
Callisto
Pharmaceuticals is involved in the development of
drugs to treat cancer and osteolytic bone diseases. |
| Cambridge Biomedical |
Cambridge Biomedical is is focused on providing custom assay development, qualification and validation services. |
| Cynvec |
Cynvec is focused on the development of the company's proprietary oncolytic sindbis viral vector for the treatment of cancer that overexpress the laminin receptor. |
| Delcath Systems |
Delcath Systems is focused on the development and commercialization of a cancer therapy that allows isolation and administration high doses of chemotherapeutic agents to a diseased organ or a region of the body to increase efficacy and decrease side effects. |
| Enumeral Biomedical |
Enumeral Biomedical is focused on the discovery of native human monoclonal antibodies using a proprietary high-density bio-chip microarray. |
| Forest
Laboratories |
Forest
Laboratories is invovled in the discovery, development,
and comercialization of drugs primarily in the areas
of central nervous system, cardiovascular, and respiratory
diseases. |
| Genzyme |
Genzyme
is a highly diversified family of companies committed
to redefining patient care worldwide through the
introduction of innovative products and services
for major unmet medical needs. |
| ImClone |
ImClone
is a biopharmaceutical company dedicated to the
development of novel treatments for cancer and
cancer-related disorders. |
| Intra-Cellular Therapies |
Intra-Cellular Therapies is focused on the research and development of drugs for the treatment of diseases and disorders of the Central Nervous System (CNS). |
| Keryx Biopharmaceuticals |
Keryx Biopharmaceuticals is focused on the acquisition, development, and commercialization of products for the treatment of patients with cancer and renal disease. |
| Manhattan Pharmaceuticals |
Manhattan Pharmaceuticals is focused on development and commercialization of treatments for vitamin B12 deficiency, head lice, essential tremor, and psoriasis. |
| NexGenix Pharmaceuticals |
NexGenix Pharmaceuticals is focused on the discovery and develompent of therapeutics for cancer and nervous system disorders. |
| Ohr Pharmaceutical |
Ohr Pharmaceutical is focused on the research and development of therapeutic drugs for for the treatment of a variety of conditions. |
| PeriCor Therapeutics |
PeriCor Therapeutics is focused the development of therapeutics to treat myocardial injury. |
| Pfizer |
Pfizer Inc. is involved in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. |
| Progenitor Cell Therapy |
Progenitor Cell Therapy is focused on providing cGMP-compliant cell manufacturing and consulting services. |
| Promosome |
Promosome is focused on the development and commercialization of a technology which enhances protein synthesis for biotherapeutics. |
| Siga
Technologies |
SIGA designs and develops novel countermeasures to prevent and treat serious infectious diseases, with an emphasis on biological warfare defense. |
| Synergy Pharmaceuticals |
Synergy Pharmaceuticals is focused on the discovery and development of drugs to treat gastrointestinal (GI) conditions and diseases. |
| Ventrus Biosciences |
Ventrus Biosciences is focused on the development of drugs for treatment of patients with gastrointestinal disorders. |
| Ziopharm Oncology |
Ziopharm Oncology is focused on the research and development of small molecule drugs for cancer. |
